Prolonged survival was also observed in breast carcinoma [193], melanoma [194], and glioblastoma-bearing mice [192] that were treated with the combination therapy (PD-(L)1 blockade and DCs) and not with either monotherapy. This evidence concerns the gene CD274 and breast carcinoma.